Stuart J. Rabin is the President and CEO as well as the Chief Investment Officer of Nine Thirty Capital, a diversified investment firm that he launched in 2004. Based in New York, Nine Thirty Capital is a flexible platform that invests in private companies as well as public securities and actively manages customized investment portfolios for prominent families and institutional clients from around the world.
From 1997 through 2008 Mr. Rabin was the President and CEO of JFI, a diversified family investment company that he co-founded. At JFI he constructed and actively managed a series of sizeable bespoke portfolios that included numerous hedge funds, an internal equity trading vehicle, direct private company investments and real estate partnerships.
Previously Mr. Rabin was employed by a New York based hedge fund, by Morgan Stanley Asset Management and by Bear Stearns & Co. Earlier in his career, Mr. Rabin practiced law with the New York firm of Skadden, Arps, Slate, Meagher & Flom and with the Washington, D.C. firm of Verner, Liipfert, Bernard, McPherson & Hand (now DLA Piper).
Mr. Rabin is the Chairman of the Board of Directors of Decision Sciences International Corporation (www.DecisionSciencesCorp.com), an advanced technology company focused on the critical mission of preventing nuclear terrorism and proliferation. Decision Sciences’ revolutionary and disruptive technology – originally developed in close cooperation with the renowned Los Alamos National Laboratory – can dramatically improve the safety and security of the global community, help to save millions of lives, and prevent the economic, psychological and civil liberties devastation likely to result from even a single act of radiological or nuclear terrorism.
Mr. Rabin is also a member of the Board of Directors of 924 Global Asset Finance Corporation and the Board of Managers of Decision Sciences Medical Company, an affiliate of Decision Sciences focused on bringing to market an advanced medical ultrasound technology for the early, non-invasive, detection of cancer and other serious medical conditions.
Nine Thirty Capital’s significant commitment to, and Mr. Rabin’s active involvement in, the business of Decision Sciences and its affiliates is illustrative of his belief that a flexible investment platform can be a model of progressive capitalism. Focusing on “doing good and doing well” can advance societal goals while simultaneously rewarding all stakeholders.
Mr. Rabin devotes substantial time and attention to charitable and civic causes, including nonprofit organizations involved in education, promoting active citizenship and illuminating Constitutional ideals, healthcare and international affairs. Mr. Rabin is a member of the Board of Trustees of the New-York Historical Society and of the National Constitution Center in Philadelphia. He serves as Chairman of the New York (Columbia) Presbyterian Health Sciences Advisory Council and is also a member of the Council on Foreign Relations, the Wharton Global Family Alliance of the Wharton School of the University of Pennsylvania, and the International Council of the Belfer Center for Science and International Affairs at the John F. Kennedy School of Government at Harvard University.
Mr. Rabin graduated with honors from Georgetown University and from the Georgetown University Law Center. He received his MBA from the Wharton School of the University of Pennsylvania.Last Updated: Jan 6, 2017, 12:57pm